Q2 2016

Filed Apr 6, 2016 · 10-Q · 37 days after period end · 0001213900-16-012280

Q2 2016 · 10-Q

Revenue

$125.00K

no prior Q2 2015 on file

Net Income

-$1.82M

N/M vs Q2 2015

EPS Diluted

$0.14

−6.7% vs Q2 2015

Operating Income-$1,912,000N/M

Operating Cash Flow

Same quarter

Metric	Q2 2016	Q2 2015	Q2 2014	Q2 2013
Revenue	$125.00K	—	—	—
Net Income	-$1.82M	-$1.64M	-$1.12M	-$1.23M
EPS Diluted	$0.14	$0.15	$0.12	-$0.17

The same fiscal quarter, prior years. Thaler holds no estimates to compare against.

Oramed Pharmaceuticals Inc. · CIK 1176309 · Engraved from SEC EDGAR